Partner at Domain Seeks Out Innovators (U-T San Diego)
April 13, 2014UT San Diego interviews partner Kim Kamdar about Domain’s leading venture investment strategies to create healthcare and life sciences companies that deliver meaningful products to patients and the industry.
More »
Domain Associates Unfazed by Biotech IPO Ups and Downs (WSJ)
April 9, 2014The Wall Street Journal interviews Nicole Vitullo, who sheds light on Domain’s stance on the current climate for biotech stocks and strategy for getting young companies to the public markets.
More »
Jim Blair’s Early Days with Amgen to New ‘Domain’ (BioWorld Today)
November 4, 2013Jim Blair’s and Domain's new investment initiatives are profiled in BioWorld Today,
More »
As ReVision Raises $55M, Domain’s Brian Dovey Assesses Rusnano Gambit (Xconomy)
July 30, 2013Xconomy interviews Brian Dovey about Domain and Rusnano’s fifth deal, joining $55 million equity round in ReVision Optics.
More »
Domain-Rusnano Partnership Invests $93 Million in Three Biotechs (Xconomy)
December 19, 2012Xconomy discusses the three Domain portfolio companies that Domain and Rusnano are investing $93 million of their joint investment agreement: Marinus Pharmaceuticals, Lithera, and Regado Biosciences.
More »